Company Profile LogoCend Therapeutics Inc.

A clinical-stage oncology biotech developing targeted anticancer drug delivery technologies for solid tumors

Edit IconSuggest an Edit
Oncology
Medical
Health Care
Biotechnology

    Unlock insights on Cend Therapeutics Inc. and 2M+ companies now!

    About Cend Therapeutics Inc.

    Cend Therapeutics Inc. is a biopharmaceutical company dedicated to developing next generation cancer therapies that are designed to overcome the barriers of drug delivery to solid tumors. The novel drug delivery platform works highly specifically in cancer tissues, thereby having the potential to maximize efficacy while minimizing the toxicity and side effects usually associated with cancer treatments. Numerous pre-clinical studies have demonstrated efficacy in multiple types of solid tumors, w

    Company Highlights
    Year Founded

    2016

    icon-altStatus

    Acquired

    icon-altEmployees

    1

    Location (HQ)

    USA

    Since Last Funding

    6 years 3 months

    icon-altTotal Investment Amt

    $3.1M

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Medical

    Health Care

    Biotechnology

    Biotechnology Research

    Oncology